Norwegian Research Council
22
2M
14
0.71
6
0.36
3
- Stages of investment
- Areas of investment
Summary
Norwegian Research Council is the famous Corporate Investor, which was founded in 1993. The leading representative office of defined Corporate Investor is situated in the Oslo. The company was established in Europe in Norway.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Norway. Among the most popular portfolio startups of the fund, we may highlight Vaccibody. Among the most successful fund investment fields, there are Quantum Computing, Artificial Intelligence. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The high activity for fund was in 2019. Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 1 - 5 millions dollars.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Norwegian Research Council, startups are often financed by Birk Venture. The meaningful sponsors for the fund in investment in the same round are Lockheed Martin, EASME - EU Executive Agency for SMEs.
Investments analytics
Analytics
- Total investments
- 22
- Lead investments
- 6
- Exits
- 3
- Rounds per year
- 0.71
- Follow on index
- 0.36
- Investments by industry
- Health Care (10)
- Medical Device (7)
- Software (6)
- Artificial Intelligence (6)
- Biotechnology (6) Show 22 more
- Investments by region
-
- Norway (21)
- Sweden (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 6M
- Group Appearance index
- 0.23
- Avg. company exit year
- 114
- Avg. multiplicator
- 0.08
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Vaccibody | 21 Jun 2013 | Biotechnology, Pharmaceutical, Clinical Trials | Seed | 864K | Oslo, Norway |
Similar funds
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.